Mettler-Toledo International (NYSE:MTD) Earns Neutral Rating from Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research note published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $1,475.00 target price on the medical instruments supplier’s stock.

Several other analysts also recently issued reports on MTD. Citigroup upped their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Bank of America upped their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Barclays lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Finally, Morgan Stanley initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 target price on the stock. Five investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,421.88 on Tuesday. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The stock has a fifty day moving average price of $1,400.52 and a two-hundred day moving average price of $1,290.13. The stock has a market capitalization of $29.05 billion, a price-to-earnings ratio of 35.46, a PEG ratio of 4.54 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts predict that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 2,000 shares of Mettler-Toledo International stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the transaction, the chief executive officer owned 3,670 shares in the company, valued at $5,367,375. This trade represents a 35.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 236 shares of the company’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the sale, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. The trade was a 59.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 19,565 shares of company stock valued at $28,683,737 over the last 90 days. 1.94% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of MTD. Russell Investments Group Ltd. boosted its holdings in Mettler-Toledo International by 29.0% in the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock worth $137,548,000 after acquiring an additional 26,171 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its position in shares of Mettler-Toledo International by 46.7% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock worth $9,245,000 after purchasing an additional 2,493 shares in the last quarter. Sound Income Strategies LLC lifted its position in shares of Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 43 shares in the last quarter. LPL Financial LLC boosted its stake in shares of Mettler-Toledo International by 16.3% in the first quarter. LPL Financial LLC now owns 5,404 shares of the medical instruments supplier’s stock valued at $6,382,000 after purchasing an additional 758 shares during the period. Finally, Acadian Asset Management LLC grew its holdings in Mettler-Toledo International by 84.9% during the 1st quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock valued at $2,965,000 after purchasing an additional 1,154 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.